vs
Foghorn Therapeutics Inc.（FHTX）与Finward Bancorp（FNWD）财务数据对比。点击上方公司名可切换其他公司
Finward Bancorp的季度营收约是Foghorn Therapeutics Inc.的1.8倍（$16.5M vs $9.2M），Finward Bancorp净利率更高（12.0% vs -234.3%，领先246.3%），Foghorn Therapeutics Inc.同比增速更快（223.8% vs 1.1%），过去两年Foghorn Therapeutics Inc.的营收复合增速更高（35.3% vs -19.1%）
Foghorn Therapeutics是一家临床阶段生物技术企业，专注于开发靶向染色质调控系统的创新疗法，用于治疗多种癌症及其他严重疾病，目前推进多款靶向候选药物管线，通过自主研发与战略合作服务全球患者群体。
Finward Bancorp是一家总部位于美国的区域性银行控股公司，主要面向本土运营区域内的个人消费者与中小企业，提供储蓄账户、各类贷款、商业融资及财富管理等零售与商业金融服务。
FHTX vs FNWD — 直观对比
营收规模更大
FNWD
是对方的1.8倍
$9.2M
营收增速更快
FHTX
高出222.7%
1.1%
净利率更高
FNWD
高出246.3%
-234.3%
两年增速更快
FHTX
近两年复合增速
-19.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $9.2M | $16.5M |
| 净利润 | $-21.7M | $2.0M |
| 毛利率 | — | — |
| 营业利润率 | -258.2% | 11.0% |
| 净利率 | -234.3% | 12.0% |
| 营收同比 | 223.8% | 1.1% |
| 净利润同比 | -11.1% | -5.6% |
| 每股收益（稀释后） | $-0.35 | $0.46 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FHTXFNWD
| Q4 25 | $9.2M | $16.5M | ||
| Q3 25 | $8.2M | $17.4M | ||
| Q2 25 | $7.6M | $16.6M | ||
| Q1 25 | $6.0M | $15.5M | ||
| Q4 24 | $2.9M | $16.3M | ||
| Q3 24 | $7.8M | $14.9M | ||
| Q2 24 | $6.9M | $14.6M | ||
| Q1 24 | $5.0M | $25.3M |
净利润FHTXFNWD
| Q4 25 | $-21.7M | $2.0M | ||
| Q3 25 | $-15.8M | $3.5M | ||
| Q2 25 | $-17.9M | $2.2M | ||
| Q1 25 | $-18.8M | $455.0K | ||
| Q4 24 | $-19.5M | $2.1M | ||
| Q3 24 | $-19.1M | $606.0K | ||
| Q2 24 | $-23.0M | $143.0K | ||
| Q1 24 | $-25.0M | $9.3M |
营业利润率FHTXFNWD
| Q4 25 | -258.2% | 11.0% | ||
| Q3 25 | -226.9% | 20.5% | ||
| Q2 25 | -279.2% | 12.7% | ||
| Q1 25 | -385.0% | 4.0% | ||
| Q4 24 | -840.5% | 16.3% | ||
| Q3 24 | -305.5% | 2.7% | ||
| Q2 24 | -386.6% | 0.9% | ||
| Q1 24 | -558.3% | 40.6% |
净利率FHTXFNWD
| Q4 25 | -234.3% | 12.0% | ||
| Q3 25 | -194.4% | 20.1% | ||
| Q2 25 | -237.3% | 12.9% | ||
| Q1 25 | -316.4% | 2.9% | ||
| Q4 24 | -682.9% | 12.9% | ||
| Q3 24 | -244.9% | 4.1% | ||
| Q2 24 | -333.6% | 1.0% | ||
| Q1 24 | -495.4% | 36.7% |
每股收益（稀释后）FHTXFNWD
| Q4 25 | $-0.35 | $0.46 | ||
| Q3 25 | $-0.25 | $0.81 | ||
| Q2 25 | $-0.28 | $0.50 | ||
| Q1 25 | $-0.30 | $0.11 | ||
| Q4 24 | $-0.23 | $0.50 | ||
| Q3 24 | $-0.31 | $0.14 | ||
| Q2 24 | $-0.45 | $0.03 | ||
| Q1 24 | $-0.59 | $2.17 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $80.9M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-108.5M | $174.7M |
| 总资产 | $198.1M | $2.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FHTXFNWD
| Q4 25 | $80.9M | — | ||
| Q3 25 | $89.3M | — | ||
| Q2 25 | $72.6M | — | ||
| Q1 25 | $61.0M | — | ||
| Q4 24 | $55.5M | — | ||
| Q3 24 | $57.7M | — | ||
| Q2 24 | $138.9M | — | ||
| Q1 24 | $79.3M | — |
股东权益FHTXFNWD
| Q4 25 | $-108.5M | $174.7M | ||
| Q3 25 | $-89.7M | $165.5M | ||
| Q2 25 | $-76.7M | $154.3M | ||
| Q1 25 | $-61.7M | $151.8M | ||
| Q4 24 | $-45.5M | $151.4M | ||
| Q3 24 | $-28.3M | $159.6M | ||
| Q2 24 | $-14.3M | $148.6M | ||
| Q1 24 | $-97.5M | $151.6M |
总资产FHTXFNWD
| Q4 25 | $198.1M | $2.0B | ||
| Q3 25 | $205.0M | $2.1B | ||
| Q2 25 | $226.2M | $2.1B | ||
| Q1 25 | $258.7M | $2.0B | ||
| Q4 24 | $284.0M | $2.1B | ||
| Q3 24 | $308.4M | $2.1B | ||
| Q2 24 | $328.6M | $2.1B | ||
| Q1 24 | $255.0M | $2.1B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.3M | $9.9M |
| 自由现金流经营现金流 - 资本支出 | — | $9.0M |
| 自由现金流率自由现金流/营收 | — | 54.8% |
| 资本支出强度资本支出/营收 | 0.0% | 5.2% |
| 现金转化率经营现金流/净利润 | — | 4.99× |
| 过去12个月自由现金流最近4个季度 | — | $10.6M |
8季度趋势，按日历期对齐
经营现金流FHTXFNWD
| Q4 25 | $-22.3M | $9.9M | ||
| Q3 25 | $-18.9M | $1.2M | ||
| Q2 25 | $-21.0M | $4.8M | ||
| Q1 25 | $-24.0M | $-3.8M | ||
| Q4 24 | $-24.5M | $9.8M | ||
| Q3 24 | $-21.0M | $-3.7M | ||
| Q2 24 | $-25.5M | $2.8M | ||
| Q1 24 | $-29.3M | $-25.0K |
自由现金流FHTXFNWD
| Q4 25 | — | $9.0M | ||
| Q3 25 | — | $1.0M | ||
| Q2 25 | $-21.0M | $4.5M | ||
| Q1 25 | $-24.0M | $-4.0M | ||
| Q4 24 | $-25.0M | $6.7M | ||
| Q3 24 | $-21.3M | $-4.2M | ||
| Q2 24 | $-25.6M | $1.1M | ||
| Q1 24 | $-29.4M | $-736.0K |
自由现金流率FHTXFNWD
| Q4 25 | — | 54.8% | ||
| Q3 25 | — | 6.0% | ||
| Q2 25 | -278.2% | 27.0% | ||
| Q1 25 | -403.2% | -25.7% | ||
| Q4 24 | -875.3% | 41.2% | ||
| Q3 24 | -273.0% | -28.5% | ||
| Q2 24 | -371.0% | 7.6% | ||
| Q1 24 | -583.1% | -2.9% |
资本支出强度FHTXFNWD
| Q4 25 | 0.0% | 5.2% | ||
| Q3 25 | 0.0% | 0.9% | ||
| Q2 25 | 0.3% | 1.7% | ||
| Q1 25 | 0.5% | 1.2% | ||
| Q4 24 | 16.8% | 18.8% | ||
| Q3 24 | 4.0% | 3.4% | ||
| Q2 24 | 0.2% | 11.2% | ||
| Q1 24 | 2.0% | 2.8% |
现金转化率FHTXFNWD
| Q4 25 | — | 4.99× | ||
| Q3 25 | — | 0.34× | ||
| Q2 25 | — | 2.22× | ||
| Q1 25 | — | -8.37× | ||
| Q4 24 | — | 4.66× | ||
| Q3 24 | — | -6.15× | ||
| Q2 24 | — | 19.23× | ||
| Q1 24 | — | -0.00× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
